- Home
- RVYL vs AEON Comparison
RVYL vs AEON Comparison
Compare RVYL & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVYL
- AEON
- Stock Information
- Founded
- RVYL 2007
- AEON N/A
- Country
- RVYL United States
- AEON United States
- Employees
- RVYL N/A
- AEON N/A
- Industry
- RVYL Professional Services
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- RVYL Consumer Discretionary
- AEON Health Care
- Exchange
- RVYL Nasdaq
- AEON Nasdaq
- Market Cap
- RVYL 7.3M
- AEON 8.0M
- IPO Year
- RVYL N/A
- AEON N/A
- Fundamental
- Price
- RVYL $0.30
- AEON $0.77
- Analyst Decision
- RVYL Hold
- AEON Strong Buy
- Analyst Count
- RVYL 1
- AEON 1
- Target Price
- RVYL N/A
- AEON $360.00
- AVG Volume (30 Days)
- RVYL 5.6M
- AEON 73.4K
- Earning Date
- RVYL 08-14-2025
- AEON 11-12-2025
- Dividend Yield
- RVYL N/A
- AEON N/A
- EPS Growth
- RVYL N/A
- AEON N/A
- EPS
- RVYL N/A
- AEON N/A
- Revenue
- RVYL $48,904,000.00
- AEON N/A
- Revenue This Year
- RVYL $27.50
- AEON N/A
- Revenue Next Year
- RVYL $35.71
- AEON N/A
- P/E Ratio
- RVYL N/A
- AEON N/A
- Revenue Growth
- RVYL N/A
- AEON N/A
- 52 Week Low
- RVYL $0.25
- AEON $0.38
- 52 Week High
- RVYL $2.35
- AEON $115.57
- Technical
- Relative Strength Index (RSI)
- RVYL 46.18
- AEON 52.49
- Support Level
- RVYL $0.27
- AEON $0.72
- Resistance Level
- RVYL $0.31
- AEON $0.80
- Average True Range (ATR)
- RVYL 0.02
- AEON 0.05
- MACD
- RVYL 0.01
- AEON 0.00
- Stochastic Oscillator
- RVYL 56.67
- AEON 65.74
About RVYL Ryvyl Inc.
Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.